Lv3
300 积分 2021-08-16 加入
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events
5天前
已完结
Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study
14天前
已完结
How infectious is the hepatitis B virus? Readings from the occult
3个月前
已完结
Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus
3个月前
已完结
Multiple HBV transfusion transmissions from undetected occult infections: revising the minimal infectious dose
3个月前
已完结
Occult Hepatitis B Virus Infection: An Update
3个月前
已完结
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference
4个月前
已完结
Expanding the Differential Diagnosis: Severe, Swollen Hepatocytes in a Patient with an ALT above 1000 U/L
5个月前
已关闭
Automated phenotyping of patients with non-alcoholic fatty liver disease reveals clinically relevant disease subtypes
5个月前
已关闭
Long-term hepatitis B surface antigen response after finite treatment of ARC-520 or JNJ-3989
6个月前
已完结
皖公网安备34019202002308
